Clinical relevance of the use of Dentoxol® for oral mucositis induced by radiotherapy: A phase II clinical trial

Table 1 Absolute frequencies and percentages of patients with and without severe oral mucositis by follow-up week

Week	Dentoxol® (n = 55)				Control (n = 53)
	No severe oral mucositis		Severe oral mucositis		No severe oral mucositis		Severe oral mucositis		P value
	n	%	n	%	n	%	n	%
1	49	94.2	3	5.8	49	98.0	1	2.0	0.327
2	49	100	0	0.0	42	95.5	2	4.5	0.131
3	47	95.9	2	4.1	30	76.9	9	23.1	0.007a
4	42	91.3	4	8.7	29	70.7	12	29.3	0.013a
5	33	73.3	12	26.7	19	52.8	17	47.2	0.055
6	29	64.4	16	35.6	15	46.9	17	53.1	0.125
7	22	57.9	16	42.1	11	44.0	14	56.0	0.280
8	11	57.7	6	35.3	4	44.4	5	55.6	0.320

^aStatistically significant.